How Should Economic Analyses Inform Nosocomial Infection Control
Bibliographic Data
| ID | 15746295 |
|---|---|
| Authors | Eleftherios Mylonakis (0000-0002-4624-0777, Brown University, corresponding author), Panayiotis D Ziakas (0000-0002-5943-8635, Public Health England) |
| Year | 2021 |
| Volume | 23 |
| Issue | 8 |
| Pages | E631-638 |
| Publication date | 2021-08-01 |
| Open Access | Yes |
| Type | ARTICLE |
| Venue | The AMA Journal of Ethic (JOURNAL) |
| Journal identifiers | ISSN: 2376-6980 • E-ISSN: 2376-6980 |
| Publisher | American Medical Association (PUBLISHER • US) |
| DOI | 10.1001/amajethics.2021.631 |
| PMID | 34459731 |
| OpenAlex | W3189469680 |
| Language | EN |
| Citations received | 1 |
| References cited | 2 |
Nosocomial infections are public health threats with often grave human costs. Because implementing screening and best outbreak response practices is costly for health care organizations, allocating resources for interventions requires consensus among stakeholders with a plurality of perspectives about how to weigh prospective interventions' risks and benefits. Economic analysis can facilitate decision making but is relatively new in nosocomial infection prevention and control. This article describes features of and reasons for economic analysis in this specific area and focuses on emerging challenges in antimicrobial stewardship
Control (management · Infection control · Intensive care medicine · Antibiotic Use and Resistance · Computer Science · Healthcare cost, quality, practices · Medicine · Patient Satisfaction in Healthcare · Artificial Intelligence
| Citations per year | 0.2 |
|---|---|
| Citation span | 2021 - 2021 (1) |
| Highly cited | No |